Dimitrios Chondros

938 citations
9 papers · 399 indexed · 1 hit paper · h-index 4
Topics
Pancreatic and Hepatic Oncology Research (6 papers)Proteoglycans and glycosaminoglycans research (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)

In The Last Decade

Dimitrios Chondros

9 papers receiving 397 citations

Hit Papers

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-P...20172026202020232017100200300

Peers

Dimitrios Chondros
Comparison fields: 5 of 42
  • Oncology 333
  • Cancer Research 117
  • Immunology 110
  • Molecular Biology 87
  • Cell Biology 48
Replace Wilson Wu with:
Wilson Wu United States
Jie Pu United States
Ines A. Silva United States
Priska Auf der Maur Switzerland
Prabhu Arumugam United Kingdom
Daiki Eguchi Japan
Changfa Qu China
Mary Topalovski United States
Anne Steins Netherlands
Emily Kantoff United States
Dimitrios Chondros relative to Wilson Wu United States Wilson Wu's profile →
Citations per field
00.5×1.5×
Wilson Wu · 1×
Citations per year

Countries citing papers authored by Dimitrios Chondros

Since Specialization
Citations

This map shows the geographic impact of Dimitrios Chondros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Chondros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Chondros more than expected).

Fields of papers citing papers by Dimitrios Chondros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Chondros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Chondros. The network helps show where Dimitrios Chondros may publish in the future.

Co-authorship network of co-authors of Dimitrios Chondros

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Chondros. A scholar is included among the top collaborators of Dimitrios Chondros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Chondros. Dimitrios Chondros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 17
2 1
3 6
4
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinomabreakdown →
365
5 4
6 1
7 1
8 3
9 1

About Dimitrios Chondros

Dimitrios Chondros is a scholar working on Hepatology, Oncology and Cell Biology, having authored 9 papers that have together received 399 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (333 citations), Cancer Research (117 citations) and Immunology (110 citations). Dimitrios Chondros has collaborated with scholars based in United States, Denmark and South Africa. Frequent co-authors include William Proctor Harris, Nathan Bahary, Mark M. Zalupski, Lei Zheng, Tara Elisabeth Seery, Carrie Aldrich, Darren Sigal, Andrea J. Bullock, Paul S. Ritch and Andrew Hendifar. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026